146 related articles for article (PubMed ID: 11376024)
1. The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study.
Pérez-Vallés A; Martorell-Cebollada M; Nogueira-Vázquez E; García-García JA; Fuster-Diana E
J Clin Pathol; 2001 Jun; 54(6):476-80. PubMed ID: 11376024
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 expression and molecular alterations in familial breast cancer.
Mangia A; Chiriatti A; Tommasi S; Menolascina F; Petroni S; Zito FA; Simone G; Schittulli F; Paradiso A
Histol Histopathol; 2009 Jan; 24(1):69-76. PubMed ID: 19012246
[TBL] [Abstract][Full Text] [Related]
3. Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.
van der Groep P; Bouter A; van der Zanden R; Siccama I; Menko FH; Gille JJ; van Kalken C; van der Wall E; Verheijen RH; van Diest PJ
J Clin Pathol; 2006 Jun; 59(6):611-7. PubMed ID: 16603649
[TBL] [Abstract][Full Text] [Related]
4. Tumour biological features of BRCA1-induced breast and ovarian cancer.
Jóhannsson OT; Idvall I; Anderson C; Borg A; Barkardóttir RB; Egilsson V; Olsson H
Eur J Cancer; 1997 Mar; 33(3):362-71. PubMed ID: 9155518
[TBL] [Abstract][Full Text] [Related]
5. Use of a BRCA1 peptide validates MS110 as a BRCA1-specific antibody in immunohistochemistry.
Alamshah A; Springall R; Gillett CE; Solomon E; Morris JR
Histopathology; 2008 Jul; 53(1):117-20. PubMed ID: 18462360
[No Abstract] [Full Text] [Related]
6. An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue.
Byrne TJ; Reece MT; Adams LA; Lane MA; Cohn GM
Oncol Rep; 2000; 7(5):949-53. PubMed ID: 10948320
[TBL] [Abstract][Full Text] [Related]
7. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
[TBL] [Abstract][Full Text] [Related]
8. Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours.
Milner R; Wombwell H; Eckersley S; Barnes D; Warwicker J; Van Dorp E; Rowlinson R; Dearden S; Hughes G; Harbron C; Wellings B; Hodgson D; Womack C; Gray N; Lau A; O'Connor MJ; Marsden C; Kvist AJ
Virchows Arch; 2013 Mar; 462(3):269-79. PubMed ID: 23354597
[TBL] [Abstract][Full Text] [Related]
9. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.
Wilson CA; Ramos L; Villaseñor MR; Anders KH; Press MF; Clarke K; Karlan B; Chen JJ; Scully R; Livingston D; Zuch RH; Kanter MH; Cohen S; Calzone FJ; Slamon DJ
Nat Genet; 1999 Feb; 21(2):236-40. PubMed ID: 9988281
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene.
Bernard-Gallon DJ; De Latour MP; Rio PG; Penault-Llorca FM; Favy DA; Hizel C; Chassagne J; Bignon YJ
Int J Oncol; 1999 Apr; 14(4):653-61. PubMed ID: 10087311
[TBL] [Abstract][Full Text] [Related]
12. Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases.
Hadjisavvas A; Mikellidou C; Zenios A; Zouvani I; Adamou A; Christodoulou Ch; Kyriacou K
Ultrastruct Pathol; 2002; 26(4):237-44. PubMed ID: 12227949
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
14. [Germ-line mutations of the BRCA1 gene in northeastern France].
Fricker JP; Muller D; Cutuli B; Rodier JF; Janser JC; Jung GM; Mors R; Petit T; Haegele P; Abecassis J
Bull Cancer; 2000 Oct; 87(10):739-44. PubMed ID: 11084537
[TBL] [Abstract][Full Text] [Related]
15. PML protein expression in hereditary and sporadic breast cancer.
Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z
Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer?
Troudi W; Uhrhammer N; Ben Romdhane K; Sibille C; Mahfoudh W; Chouchane L; Ben Ayed F; Bignon YJ; Ben Ammar Elgaaied A
Eur J Histochem; 2007; 51(3):219-26. PubMed ID: 17921118
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
Butcher DT; Rodenhiser DI
Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
